| Pectinatus| Pectinatus Lee et al. 1978 (Approved Lists 1980) emend. Caldwell et al. 2013| Pectinatus Lee et al. 1978 (Approved Lists 1980) emend. Juvonen and Suihko 2006
Infections: In rare cases, Pectinatus species have been isolated from clinical specimens, particularly in patients with underlying health conditions or immunocompromised individuals. These infections may include abscesses, wound infections, or polymicrobial infections in various body sites. However, Pectinatus is not commonly considered a primary pathogen in human disease.
Gastrointestinal health: While Pectinatus species are part of the normal microbiota of the human gastrointestinal tract, their role in gut health or disease is not well-understood. Dysbiosis, or an imbalance in the gut microbiota, has been implicated in various gastrointestinal disorders, and alterations in the abundance of Pectinatus or other anaerobic bacteria may potentially contribute to such conditions. However, specific associations between Pectinatus and gastrointestinal health have not been extensively studied.
Bioremediation: Some species of Pectinatus have been studied for their potential use in bioremediation processes, such as the removal of pollutants or organic compounds from contaminated environments. While this is not a direct health impact on humans, it highlights the ecological importance and potential applications of Pectinatus bacteria in environmental science and technology.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.79 | 4 | 973 | 0 | 634 | 168.8 | 96 | 237.2 | 4 | 973 | 0 %ile | 100 %ile | ||
biomesight | 79.04 | 0 | 170 | 10 | 300 | 0 | 740 | 189.3 | 90 | 281 | 0 | 370 | 0 %ile | 90.9 %ile |
thorne | 86.21 | 1 | 47 | 0 | 27 | 8.6 | 6 | 9.2 | 2 | 12 | 0 %ile | 100 %ile | ||
thryve | 15.07 | 0 | 7 | 1 | 1672 | 0 | 347 | 60.5 | 28 | 145.9 | 8 | 74 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 0 | 0 | 0 | 0 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 85.228 % | 0.02 % | 0.05 % | 2527.0 | 2965 |
BiomeSightRdp | 38.71 % | 0.007 % | 0.006 % | 12.0 | 31 |
CerbaLab | 100 % | 0.008 % | 0.003 % | 3.0 | 3 |
custom | 3.279 % | 0.002 % | 0.002 % | 2.0 | 61 |
Medivere | 100 % | 0.032 % | 0.033 % | 7.0 | 7 |
SequentiaBiotech | 2.778 % | 0.014 % | % | 1.0 | 36 |
Thorne | 60.577 % | 0.001 % | 0.001 % | 63.0 | 104 |
Thryve | 14.871 % | 0.006 % | 0.014 % | 207.0 | 1392 |
|
And display level must be raised above public.
Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.